BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kreda SM, Davis CW, Rose MC. CFTR, mucins, and mucus obstruction in cystic fibrosis. Cold Spring Harb Perspect Med 2012;2:a009589. [PMID: 22951447 DOI: 10.1101/cshperspect.a009589] [Cited by in Crossref: 128] [Cited by in F6Publishing: 114] [Article Influence: 12.8] [Reference Citation Analysis]
Number Citing Articles
1 Bazett M, Honeyman L, Stefanov AN, Pope CE, Hoffman LR, Haston CK. Cystic fibrosis mouse model-dependent intestinal structure and gut microbiome. Mamm Genome 2015;26:222-34. [PMID: 25721416 DOI: 10.1007/s00335-015-9560-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
2 Massip-Copiz MM, Santa-Coloma TA. Extracellular pH and lung infections in cystic fibrosis. Eur J Cell Biol 2018;97:402-10. [PMID: 29933921 DOI: 10.1016/j.ejcb.2018.06.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
3 Deschemin JC, Allouche S, Brouillard F, Vaulont S. Iron Homeostasis and Inflammatory Status in Mice Deficient for the Cystic Fibrosis Transmembrane Regulator. PLoS One 2015;10:e0145685. [PMID: 26709821 DOI: 10.1371/journal.pone.0145685] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
4 Button B, Okada SF, Frederick CB, Thelin WR, Boucher RC. Mechanosensitive ATP release maintains proper mucus hydration of airways. Sci Signal 2013;6:ra46. [PMID: 23757023 DOI: 10.1126/scisignal.2003755] [Cited by in Crossref: 51] [Cited by in F6Publishing: 56] [Article Influence: 5.7] [Reference Citation Analysis]
5 Harris WT, Boyd JT, McPhail GL, Brody AS, Szczesniak RD, Korbee LL, Baker ML, Clancy JP. Constrictive Bronchiolitis in Cystic Fibrosis Adolescents with Refractory Pulmonary Decline. Ann Am Thorac Soc 2016;13:2174-83. [PMID: 27684511 DOI: 10.1513/AnnalsATS.201412-594OC] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
6 Quinton PM. Both Ways at Once: Keeping Small Airways Clean. Physiology 2017;32:380-90. [DOI: 10.1152/physiol.00013.2017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
7 AbdulWahab A, Zahraldin K, Sid Ahmed MA, Jarir SA, Muneer M, Mohamed SF, Hamid JM, Hassan AAI, Ibrahim EB. The emergence of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis patients on inhaled antibiotics. Lung India 2017;34:527-31. [PMID: 29098998 DOI: 10.4103/lungindia.lungindia_39_17] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
8 Chen Y, Garvin LM, Nickola TJ, Watson AM, Colberg-Poley AM, Rose MC. IL-1β induction of MUC5AC gene expression is mediated by CREB and NF-κB and repressed by dexamethasone. Am J Physiol Lung Cell Mol Physiol 2014;306:L797-807. [PMID: 24487386 DOI: 10.1152/ajplung.00347.2013] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 5.4] [Reference Citation Analysis]
9 Vitko M, Valerio DM, Rye PD, Onsøyen E, Myrset AH, Dessen A, Drumm ML, Hodges CA. A novel guluronate oligomer improves intestinal transit and survival in cystic fibrosis mice. Journal of Cystic Fibrosis 2016;15:745-51. [DOI: 10.1016/j.jcf.2016.06.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
10 Schultz A, Puvvadi R, Borisov SM, Shaw NC, Klimant I, Berry LJ, Montgomery ST, Nguyen T, Kreda SM, Kicic A, Noble PB, Button B, Stick SM. Airway surface liquid pH is not acidic in children with cystic fibrosis. Nat Commun 2017;8:1409. [PMID: 29123085 DOI: 10.1038/s41467-017-00532-5] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 11.8] [Reference Citation Analysis]
11 Adam RJ, Michalski AS, Bauer C, Abou Alaiwa MH, Gross TJ, Awadalla MS, Bouzek DC, Gansemer ND, Taft PJ, Hoegger MJ, Diwakar A, Ochs M, Reinhardt JM, Hoffman EA, Beichel RR, Meyerholz DK, Stoltz DA. Air trapping and airflow obstruction in newborn cystic fibrosis piglets. Am J Respir Crit Care Med 2013;188:1434-41. [PMID: 24168209 DOI: 10.1164/rccm.201307-1268OC] [Cited by in Crossref: 49] [Cited by in F6Publishing: 24] [Article Influence: 6.1] [Reference Citation Analysis]
12 Rao MC. Physiology of Electrolyte Transport in the Gut: Implications for Disease. Compr Physiol 2019;9:947-1023. [PMID: 31187895 DOI: 10.1002/cphy.c180011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
13 Corfield A. Eukaryotic protein glycosylation: a primer for histochemists and cell biologists. Histochem Cell Biol 2017;147:119-47. [PMID: 28012131 DOI: 10.1007/s00418-016-1526-4] [Cited by in Crossref: 78] [Cited by in F6Publishing: 72] [Article Influence: 13.0] [Reference Citation Analysis]
14 Ambort D, Johansson ME, Gustafsson JK, Ermund A, Hansson GC. Perspectives on mucus properties and formation--lessons from the biochemical world. Cold Spring Harb Perspect Med 2012;2:a014159. [PMID: 23125206 DOI: 10.1101/cshperspect.a014159] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 3.9] [Reference Citation Analysis]
15 Liao YSJ, Kuan SP, Guevara MV, Collins EN, Atanasova KR, Dadural JS, Vogt K, Schurmann V, Bravo L, Eken E, Sponchiado M, Reznikov LR. Acid exposure disrupts mucus secretion and impairs mucociliary transport in neonatal piglet airways. Am J Physiol Lung Cell Mol Physiol 2020;318:L873-87. [PMID: 32160007 DOI: 10.1152/ajplung.00025.2020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
16 Rhoads A, Au KF. PacBio Sequencing and Its Applications. Genomics Proteomics Bioinformatics 2015;13:278-89. [PMID: 26542840 DOI: 10.1016/j.gpb.2015.08.002] [Cited by in Crossref: 923] [Cited by in F6Publishing: 698] [Article Influence: 131.9] [Reference Citation Analysis]
17 Liu J, Walker NM, Ootani A, Strubberg AM, Clarke LL. Defective goblet cell exocytosis contributes to murine cystic fibrosis-associated intestinal disease. J Clin Invest. 2015;125:1056-1068. [PMID: 25642775 DOI: 10.1172/jci73193] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 4.7] [Reference Citation Analysis]
18 Tony-odigie A, Wilke L, Boutin S, Dalpke AH, Yi B. Commensal Bacteria in the Cystic Fibrosis Airway Microbiome Reduce P. aeruginosa Induced Inflammation. Front Cell Infect Microbiol 2022;12:824101. [DOI: 10.3389/fcimb.2022.824101] [Reference Citation Analysis]
19 Hadjiliadis D, Khoruts A, Zauber AG, Hempstead SE, Maisonneuve P, Lowenfels AB; Cystic Fibrosis Colorectal Cancer Screening Task Force. Cystic Fibrosis Colorectal Cancer Screening Consensus Recommendations. Gastroenterology. 2018;154:736-745.e14. [PMID: 29289528 DOI: 10.1053/j.gastro.2017.12.012] [Cited by in Crossref: 57] [Cited by in F6Publishing: 38] [Article Influence: 11.4] [Reference Citation Analysis]
20 Khan MA, Khan ZA, Charles M, Pratap P, Naeem A, Siddiqui Z, Naqvi N, Srivastava S. Cytokine Storm and Mucus Hypersecretion in COVID-19: Review of Mechanisms. J Inflamm Res. 2021;14:175-189. [PMID: 33519225 DOI: 10.2147/jir.s271292] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 10.0] [Reference Citation Analysis]
21 Simões FB, Quaresma MC, Clarke LA, Silva IA, Pankonien I, Railean V, Kmit A, Amaral MD. TMEM16A chloride channel does not drive mucus production. Life Sci Alliance 2019;2:e201900462. [PMID: 31732694 DOI: 10.26508/lsa.201900462] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
22 Puccetti M, Pariano M, Renga G, Santarelli I, D'Onofrio F, Bellet MM, Stincardini C, Bartoli A, Costantini C, Romani L, Ricci M, Giovagnoli S. Targeted Drug Delivery Technologies Potentiate the Overall Therapeutic Efficacy of an Indole Derivative in a Mouse Cystic Fibrosis Setting. Cells 2021;10:1601. [PMID: 34202407 DOI: 10.3390/cells10071601] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Castellani S, Di Gioia S, di Toma L, Conese M. Human Cellular Models for the Investigation of Lung Inflammation and Mucus Production in Cystic Fibrosis. Anal Cell Pathol (Amst) 2018;2018:3839803. [PMID: 30581723 DOI: 10.1155/2018/3839803] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
24 Tyrrell J, Tarran R. Gaining the Upper Hand on Pulmonary Drug Delivery. J Pharmacovigil 2014;2:118. [PMID: 25126589 DOI: 10.4172/2329-6887.1000118] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
25 Kamei S, Fujikawa H, Nohara H, Ueno-Shuto K, Maruta K, Nakashima R, Kawakami T, Matsumoto C, Sakaguchi Y, Ono T, Suico MA, Boucher RC, Gruenert DC, Takeo T, Nakagata N, Li JD, Kai H, Shuto T. Zinc Deficiency via a Splice Switch in Zinc Importer ZIP2/SLC39A2 Causes Cystic Fibrosis-Associated MUC5AC Hypersecretion in Airway Epithelial Cells. EBioMedicine 2018;27:304-16. [PMID: 29289532 DOI: 10.1016/j.ebiom.2017.12.025] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
26 Abdullah LH, Evans JR, Wang TT, Ford AA, Makhov AM, Nguyen K, Coakley RD, Griffith JD, Davis CW, Ballard ST, Kesimer M. Defective postsecretory maturation of MUC5B mucin in cystic fibrosis airways. JCI Insight 2017;2:e89752. [PMID: 28352653 DOI: 10.1172/jci.insight.89752] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
27 Carsin A, Romain T, Ranque S, Reynaud-Gaubert M, Dubus JC, Mège JL, Vitte J. Aspergillus fumigatus in cystic fibrosis: An update on immune interactions and molecular diagnostics in allergic bronchopulmonary aspergillosis. Allergy 2017;72:1632-42. [PMID: 28513848 DOI: 10.1111/all.13204] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 4.4] [Reference Citation Analysis]
28 Twigg MS, Brockbank S, Lowry P, FitzGerald SP, Taggart C, Weldon S. The Role of Serine Proteases and Antiproteases in the Cystic Fibrosis Lung. Mediators Inflamm. 2015;2015:293053. [PMID: 26185359 DOI: 10.1155/2015/293053] [Cited by in Crossref: 69] [Cited by in F6Publishing: 61] [Article Influence: 9.9] [Reference Citation Analysis]
29 Sousa AM, Pereira MO. Pseudomonas aeruginosa Diversification during Infection Development in Cystic Fibrosis Lungs-A Review. Pathogens 2014;3:680-703. [PMID: 25438018 DOI: 10.3390/pathogens3030680] [Cited by in Crossref: 130] [Cited by in F6Publishing: 124] [Article Influence: 16.3] [Reference Citation Analysis]
30 Daly SM, Sturge CR, Marshall-Batty KR, Felder-Scott CF, Jain R, Geller BL, Greenberg DE. Antisense Inhibitors Retain Activity in Pulmonary Models of Burkholderia Infection. ACS Infect Dis 2018;4:806-14. [PMID: 29461800 DOI: 10.1021/acsinfecdis.7b00235] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
31 Chen G, Volmer AS, Wilkinson KJ, Deng Y, Jones LC, Yu D, Bustamante-Marin XM, Burns KA, Grubb BR, O'Neal WK, Livraghi-Butrico A, Boucher RC. Role of Spdef in the Regulation of Muc5b Expression in the Airways of Naive and Mucoobstructed Mice. Am J Respir Cell Mol Biol 2018;59:383-96. [PMID: 29579396 DOI: 10.1165/rcmb.2017-0127OC] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
32 McShane AJ, Bajrami B, Ramos AA, Diego-Limpin PA, Farrokhi V, Coutermarsh BA, Stanton BA, Jensen T, Riordan JR, Wetmore D, Joseloff E, Yao X. Targeted proteomic quantitation of the absolute expression and turnover of cystic fibrosis transmembrane conductance regulator in the apical plasma membrane. J Proteome Res 2014;13:4676-85. [PMID: 25227318 DOI: 10.1021/pr5006795] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
33 Li J, Hao C, Ren L, Xiao Y, Wang J, Qin X. Data Mining of Lung Microbiota in Cystic Fibrosis Patients. PLoS One 2016;11:e0164510. [PMID: 27741283 DOI: 10.1371/journal.pone.0164510] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
34 Wang F, Panjwani N, Wang C, Sun L, Strug LJ. A flexible summary statistics-based colocalization method with application to the mucin cystic fibrosis lung disease modifier locus. Am J Hum Genet 2022;109:253-69. [PMID: 35065708 DOI: 10.1016/j.ajhg.2021.12.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
35 Ong V, Mei V, Cao L, Lee K, Chung EJ. Nanomedicine for Cystic Fibrosis. SLAS Technol 2019;24:169-80. [PMID: 30707858 DOI: 10.1177/2472630318824334] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
36 Abdulwahab A, Allangawi M, Thomas M, Bettahi I, Sivaraman SK, Jerobin J, Chandra P, Abou-samra A, Ramanjaneya M. Sputum and plasma adiponectin levels in clinically stable adult cystic fibrosis patients with CFTR I1234V mutation. transl med commun 2020;5. [DOI: 10.1186/s41231-020-00053-2] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Starr CG, Maderdrut JL, He J, Coy DH, Wimley WC. Pituitary adenylate cyclase-activating polypeptide is a potent broad-spectrum antimicrobial peptide: Structure-activity relationships. Peptides 2018;104:35-40. [PMID: 29654809 DOI: 10.1016/j.peptides.2018.04.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
38 Neff SL, Hampton TH, Puerner C, Cengher L, Doing G, Lee AJ, Koeppen K, Cheung AL, Hogan DA, Cramer RA, Stanton BA. CF-Seq, an accessible web application for rapid re-analysis of cystic fibrosis pathogen RNA sequencing studies. Sci Data 2022;9:343. [PMID: 35710652 DOI: 10.1038/s41597-022-01431-1] [Reference Citation Analysis]
39 Shumilov D, Popov A, Fudala R, Akopova I, Gryczynski I, Borejdo J, Gryczynski Z, Grygorczyk R. Real-time imaging of exocytotic mucin release and swelling in Calu-3 cells using acridine orange. Methods 2014;66:312-24. [PMID: 24055436 DOI: 10.1016/j.ymeth.2013.09.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
40 McCauley HA, Guasch G. Three cheers for the goblet cell: maintaining homeostasis in mucosal epithelia. Trends Mol Med. 2015;21:492-503. [PMID: 26144290 DOI: 10.1016/j.molmed.2015.06.003] [Cited by in Crossref: 82] [Cited by in F6Publishing: 79] [Article Influence: 11.7] [Reference Citation Analysis]
41 Xu-Chen X, Weinstock J, Rastogi D, Koumbourlis A, Nino G. The airway epithelium during infancy and childhood: A complex multicellular immune barrier. Basic review for clinicians. Paediatr Respir Rev 2021;38:9-15. [PMID: 34030977 DOI: 10.1016/j.prrv.2021.04.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 McColley SA, Konstan MW, Ramsey BW, Stuart Elborn J, Boyle MP, Wainwright CE, Waltz D, Vera-Llonch M, Marigowda G, Jiang JG, Rubin JL. Lumacaftor/Ivacaftor reduces pulmonary exacerbations in patients irrespective of initial changes in FEV1. J Cyst Fibros 2019;18:94-101. [PMID: 30146268 DOI: 10.1016/j.jcf.2018.07.011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
43 Flynn S, Reen FJ, Caparrós-Martín JA, Woods DF, Peplies J, Ranganathan SC, Stick SM, O'Gara F. Bile Acid Signal Molecules Associate Temporally with Respiratory Inflammation and Microbiome Signatures in Clinically Stable Cystic Fibrosis Patients. Microorganisms 2020;8:E1741. [PMID: 33172004 DOI: 10.3390/microorganisms8111741] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
44 Amaral MD, Balch WE. Hallmarks of therapeutic management of the cystic fibrosis functional landscape. J Cyst Fibros 2015;14:687-99. [PMID: 26526359 DOI: 10.1016/j.jcf.2015.09.006] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
45 Massip Copiz MM, Santa Coloma TA. c- Src and its role in cystic fibrosis. European Journal of Cell Biology 2016;95:401-13. [DOI: 10.1016/j.ejcb.2016.08.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
46 Flynn JM, Niccum D, Dunitz JM, Hunter RC. Evidence and Role for Bacterial Mucin Degradation in Cystic Fibrosis Airway Disease. PLoS Pathog 2016;12:e1005846. [PMID: 27548479 DOI: 10.1371/journal.ppat.1005846] [Cited by in Crossref: 104] [Cited by in F6Publishing: 87] [Article Influence: 17.3] [Reference Citation Analysis]
47 Manniello MD, Del Gaudio P, Aquino RP, Russo P. Clarithromycin and N -acetylcysteine co-spray-dried powders for pulmonary drug delivery: A focus on drug solubility. International Journal of Pharmaceutics 2017;533:463-9. [DOI: 10.1016/j.ijpharm.2017.03.079] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
48 Chillappagari S, Müller C, Mahavadi P, Guenther A, Nährlich L, Rosenblum J, Rubin BK, Henke MO. A small molecule neutrophil elastase inhibitor, KRP-109, inhibits cystic fibrosis mucin degradation. J Cyst Fibros 2016;15:325-31. [PMID: 26526358 DOI: 10.1016/j.jcf.2015.10.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
49 Rye PD, Tøndervik A, Sletta H, Pritchard M, Kristiansen A, Dessen A, Thomas DW. Alginate Oligomers and Their Use as Active Pharmaceutical Drugs. In: Rehm BH, Moradali MF, editors. Alginates and Their Biomedical Applications. Singapore: Springer; 2018. pp. 237-56. [DOI: 10.1007/978-981-10-6910-9_10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
50 Guo X, Pace RG, Stonebraker JR, O'Neal WK, Knowles MR. Meconium ileus in cystic fibrosis is not linked to central repetitive region length variation in MUC1, MUC2, and MUC5AC. J Cyst Fibros 2014;13:613-6. [PMID: 24920497 DOI: 10.1016/j.jcf.2014.05.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
51 Chakraborti S, Sarkar J, Pramanik PK, Chakraborti T. Role of Proteases in Lung Disease: A Brief Overview. In: Chakraborti S, Chakraborti T, Dhalla NS, editors. Proteases in Human Diseases. Singapore: Springer; 2017. pp. 333-74. [DOI: 10.1007/978-981-10-3162-5_16] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
52 Kotnala S, Dhasmana A, Kashyap VK, Chauhan SC, Yallapu MM, Jaggi M. A bird eye view on cystic fibrosis: An underestimated multifaceted chronic disorder. Life Sci 2021;268:118959. [PMID: 33383045 DOI: 10.1016/j.lfs.2020.118959] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
53 Ramalho AS, Clarke LA, Sousa M, Felicio V, Barreto C, Lopes C, Amaral MD. Comparative ex vivo, in vitro and in silico analyses of a CFTR splicing mutation: Importance of functional studies to establish disease liability of mutations. J Cyst Fibros 2016;15:21-33. [PMID: 25735457 DOI: 10.1016/j.jcf.2015.02.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
54 Culp DJ, Robinson B, Cash MN, Bhattacharyya I, Stewart C, Cuadra-Saenz G. Salivary mucin 19 glycoproteins: innate immune functions in Streptococcus mutans-induced caries in mice and evidence for expression in human saliva. J Biol Chem 2015;290:2993-3008. [PMID: 25512380 DOI: 10.1074/jbc.M114.597906] [Cited by in Crossref: 32] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
55 Chillappagari S, Venkatesan S, Garapati V, Mahavadi P, Munder A, Seubert A, Sarode G, Guenther A, Schmeck BT, Tümmler B, Henke MO. Impaired TLR4 and HIF expression in cystic fibrosis bronchial epithelial cells downregulates hemeoxygenase-1 and alters iron homeostasis in vitro. American Journal of Physiology-Lung Cellular and Molecular Physiology 2014;307:L791-9. [DOI: 10.1152/ajplung.00167.2014] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
56 Cohen JD, Sparacio AP, Belfi AC, Forman-Rubinsky R, Hall DH, Maul-Newby H, Frand AR, Sundaram MV. A multi-layered and dynamic apical extracellular matrix shapes the vulva lumen in Caenorhabditis elegans. Elife 2020;9:e57874. [PMID: 32975517 DOI: 10.7554/eLife.57874] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
57 Cholon DM, Gentzsch M. Recent progress in translational cystic fibrosis research using precision medicine strategies. J Cyst Fibros 2018;17:S52-60. [PMID: 28986017 DOI: 10.1016/j.jcf.2017.09.005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 5.6] [Reference Citation Analysis]
58 Kołodziej M, de Veer MJ, Cholewa M, Egan GF, Thompson BR. Lung function imaging methods in Cystic Fibrosis pulmonary disease. Respir Res 2017;18:96. [PMID: 28514950 DOI: 10.1186/s12931-017-0578-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
59 Cantero-Recasens G, Butnaru CM, Brouwers N, Mitrovic S, Valverde MA, Malhotra V. Sodium channel TRPM4 and sodium/calcium exchangers (NCX) cooperate in the control of Ca2+-induced mucin secretion from goblet cells. J Biol Chem 2019;294:816-26. [PMID: 30482841 DOI: 10.1074/jbc.RA117.000848] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
60 Pacheco DP, Butnarasu CS, Briatico Vangosa F, Pastorino L, Visai L, Visentin S, Petrini P. Disassembling the complexity of mucus barriers to develop a fast screening tool for early drug discovery. J Mater Chem B 2019;7:4940-52. [PMID: 31411620 DOI: 10.1039/c9tb00957d] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
61 Balmuri SR, Waters NG, Hegemann J, Kierfeld J, Niepa THR. Material properties of interfacial films of mucoid and nonmucoid Pseudomonas aeruginosa isolates. Acta Biomater 2020;118:129-40. [PMID: 33053427 DOI: 10.1016/j.actbio.2020.10.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Heidari-Khoei H, Esfandiari F, Hajari MA, Ghorbaninejad Z, Piryaei A, Baharvand H. Organoid technology in female reproductive biomedicine. Reprod Biol Endocrinol 2020;18:64. [PMID: 32552764 DOI: 10.1186/s12958-020-00621-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
63 Guiu A, Buendía B, Llorca L, Gómez Punter RM, Girón R. Chryseobacterium spp., ¿nuevo patógeno oportunista asociado a fibrosis quística? Enfermedades Infecciosas y Microbiología Clínica 2014;32:497-501. [DOI: 10.1016/j.eimc.2013.08.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
64 Molina SA, Hunt WR. Cystic Fibrosis. Lung Epithelial Biology in the Pathogenesis of Pulmonary Disease. Elsevier; 2017. pp. 219-49. [DOI: 10.1016/b978-0-12-803809-3.00012-9] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
65 Zhang Q, Wang Y, Qu D, Yu J, Yang J. The Possible Pathogenesis of Idiopathic Pulmonary Fibrosis considering MUC5B. Biomed Res Int 2019;2019:9712464. [PMID: 31309122 DOI: 10.1155/2019/9712464] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
66 Pezzulo AA, Tudas RA, Stewart CG, Buonfiglio LGV, Lindsay BD, Taft PJ, Gansemer ND, Zabner J. HSP90 inhibitor geldanamycin reverts IL-13- and IL-17-induced airway goblet cell metaplasia. J Clin Invest 2019;129:744-58. [PMID: 30640172 DOI: 10.1172/JCI123524] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
67 Caballero I, Ringot-Destrez B, Si-Tahar M, Barbry P, Guillon A, Lantier I, Berri M, Chevaleyre C, Fleurot I, Barc C, Ramphal R, Pons N, Paquet A, Lebrigand K, Baron C, Bähr A, Klymiuk N, Léonard R, Robbe-Masselot C. Evidence of early increased sialylation of airway mucins and defective mucociliary clearance in CFTR-deficient piglets. J Cyst Fibros 2021;20:173-82. [PMID: 32978064 DOI: 10.1016/j.jcf.2020.09.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
68 Shaikh SR, Fessler MB, Gowdy KM. Role for phospholipid acyl chains and cholesterol in pulmonary infections and inflammation. J Leukoc Biol 2016;100:985-97. [PMID: 27286794 DOI: 10.1189/jlb.4VMR0316-103R] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
69 Müller L, Murgia X, Siebenbürger L, Börger C, Schwarzkopf K, Sewald K, Häussler S, Braun A, Lehr C, Hittinger M, Wronski S. Human airway mucus alters susceptibility of Pseudomonas aeruginosa biofilms to tobramycin, but not colistin. Journal of Antimicrobial Chemotherapy 2018;73:2762-9. [DOI: 10.1093/jac/dky241] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
70 Kim J, Dunn AC. Soft hydrated sliding interfaces as complex fluids. Soft Matter 2016;12:6536-46. [DOI: 10.1039/c6sm00623j] [Cited by in Crossref: 20] [Cited by in F6Publishing: 1] [Article Influence: 3.3] [Reference Citation Analysis]
71 Assani K, Tazi MF, Amer AO, Kopp BT. IFN-γ stimulates autophagy-mediated clearance of Burkholderia cenocepacia in human cystic fibrosis macrophages. PLoS One 2014;9:e96681. [PMID: 24798083 DOI: 10.1371/journal.pone.0096681] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 5.1] [Reference Citation Analysis]
72 Chen Q, Suresh Kumar V, Finn J, Jiang D, Liang J, Zhao YY, Liu Y. CD44high alveolar type II cells show stem cell properties during steady-state alveolar homeostasis. Am J Physiol Lung Cell Mol Physiol 2017;313:L41-51. [PMID: 28473330 DOI: 10.1152/ajplung.00564.2016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
73 Jaques R, Shakeel A, Hoyle C. Novel therapeutic approaches for the management of cystic fibrosis. Multidiscip Respir Med 2020;15:690. [PMID: 33282281 DOI: 10.4081/mrm.2020.690] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
74 Billings JL, Dunitz JM, McAllister S, Herzog T, Bobr A, Khoruts A. Early colon screening of adult patients with cystic fibrosis reveals high incidence of adenomatous colon polyps. J Clin Gastroenterol. 2014;48:e85-e88. [PMID: 24275715 DOI: 10.1097/mcg.0000000000000034] [Cited by in Crossref: 29] [Cited by in F6Publishing: 16] [Article Influence: 4.1] [Reference Citation Analysis]
75 Cross AR, Goldberg JB. Remodeling of O Antigen in Mucoid Pseudomonas aeruginosa via Transcriptional Repression of wzz2. mBio 2019;10:e02914-18. [PMID: 30782665 DOI: 10.1128/mBio.02914-18] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
76 Cantero-Recasens G, Butnaru CM, Valverde MA, Naranjo JR, Brouwers N, Malhotra V. KChIP3 coupled to Ca2+ oscillations exerts a tonic brake on baseline mucin release in the colon. Elife 2018;7:e39729. [PMID: 30272559 DOI: 10.7554/eLife.39729] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
77 Shashikanth N, Yeruva S, Ong MLDM, Odenwald MA, Pavlyuk R, Turner JR. Epithelial Organization: The Gut and Beyond. In: Terjung R, editor. Comprehensive Physiology. Wiley; 2011. pp. 1497-518. [DOI: 10.1002/cphy.c170003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
78 Recchiuti A, Mattoscio D, Isopi E. Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis. Front Pharmacol 2019;10:252. [PMID: 31001110 DOI: 10.3389/fphar.2019.00252] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
79 Loftus CA, Yoo F, Desiato VM, Schlosser RJ, Soler ZM. Treatment of Recalcitrant Maxillary Sinusitis With Endoscopic Modified Medial Maxillectomy: A Systematic Review of Safety and Efficacy. Am J Rhinol Allergy 2020;34:127-33. [PMID: 31537079 DOI: 10.1177/1945892419876394] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
80 Ehre C, Ridley C, Thornton DJ. Cystic fibrosis: an inherited disease affecting mucin-producing organs. Int J Biochem Cell Biol 2014;52:136-45. [PMID: 24685676 DOI: 10.1016/j.biocel.2014.03.011] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 7.0] [Reference Citation Analysis]
81 Qin S, Tang X, Chen Y, Chen K, Fan N, Xiao W, Zheng Q, Li G, Teng Y, Wu M, Song X. mRNA-based therapeutics: powerful and versatile tools to combat diseases. Signal Transduct Target Ther 2022;7:166. [PMID: 35597779 DOI: 10.1038/s41392-022-01007-w] [Reference Citation Analysis]
82 Li SS, Saleh M, Xiang RF, Ogbomo H, Stack D, Huston SH, Mody CH. Natural killer cells kill Burkholderia cepacia complex via a contact-dependent and cytolytic mechanism. Int Immunol 2019;31:385-96. [PMID: 31051036 DOI: 10.1093/intimm/dxz016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
83 Pallett R, Leslie LJ, Lambert PA, Milic I, Devitt A, Marshall LJ. Anaerobiosis influences virulence properties of Pseudomonas aeruginosa cystic fibrosis isolates and the interaction with Staphylococcus aureus. Sci Rep 2019;9:6748. [PMID: 31043640 DOI: 10.1038/s41598-019-42952-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
84 Guo M, Tomoshige K, Meister M, Muley T, Fukazawa T, Tsuchiya T, Karns R, Warth A, Fink-Baldauf IM, Nagayasu T, Naomoto Y, Xu Y, Mall MA, Maeda Y. Gene signature driving invasive mucinous adenocarcinoma of the lung. EMBO Mol Med 2017;9:462-81. [PMID: 28255028 DOI: 10.15252/emmm.201606711] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 8.4] [Reference Citation Analysis]
85 Flynn JM, Phan C, Hunter RC. Genome-Wide Survey of Pseudomonas aeruginosa PA14 Reveals a Role for the Glyoxylate Pathway and Extracellular Proteases in the Utilization of Mucin. Infect Immun 2017;85:e00182-17. [PMID: 28507068 DOI: 10.1128/IAI.00182-17] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
86 Wine JJ, Hansson GC, König P, Joo NS, Ermund A, Pieper M. Progress in understanding mucus abnormalities in cystic fibrosis airways. J Cyst Fibros 2018;17:S35-9. [PMID: 28951068 DOI: 10.1016/j.jcf.2017.09.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
87 Morin C, Cantin AM, Rousseau É, Sirois M, Sirois C, Rizcallah E, Fortin S. Proresolving Action of Docosahexaenoic Acid Monoglyceride in Lung Inflammatory Models Related to Cystic Fibrosis. Am J Respir Cell Mol Biol 2015;53:574-83. [PMID: 25781052 DOI: 10.1165/rcmb.2014-0223OC] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
88 Conese M, Di Gioia S. Pathophysiology of Lung Disease and Wound Repair in Cystic Fibrosis. Pathophysiology 2021;28:155-88. [PMID: 35366275 DOI: 10.3390/pathophysiology28010011] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
89 Chisholm JF, Shenoy SK, Shade JK, Kim V, Putcha N, Carson KA, Wise R, Hansel NN, Hanes JS, Suk JS, Neptune E. Nanoparticle diffusion in spontaneously expectorated sputum as a biophysical tool to probe disease severity in COPD. Eur Respir J 2019;54:1900088. [PMID: 31164433 DOI: 10.1183/13993003.00088-2019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
90 Boucherat O, Boczkowski J, Jeannotte L, Delacourt C. Cellular and molecular mechanisms of goblet cell metaplasia in the respiratory airways. Experimental Lung Research 2013;39:207-16. [DOI: 10.3109/01902148.2013.791733] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 5.0] [Reference Citation Analysis]
91 Jaramillo AM, Piccotti L, Velasco WV, Delgado ASH, Azzegagh Z, Chung F, Nazeer U, Farooq J, Brenner J, Parker-Thornburg J, Scott BL, Evans CM, Adachi R, Burns AR, Kreda SM, Tuvim MJ, Dickey BF. Different Munc18 proteins mediate baseline and stimulated airway mucin secretion. JCI Insight 2019;4:124815. [PMID: 30721150 DOI: 10.1172/jci.insight.124815] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
92 Caswell JL. Failure of respiratory defenses in the pathogenesis of bacterial pneumonia of cattle. Vet Pathol 2014;51:393-409. [PMID: 24021557 DOI: 10.1177/0300985813502821] [Cited by in Crossref: 71] [Cited by in F6Publishing: 61] [Article Influence: 7.9] [Reference Citation Analysis]
93 Chmelař D, Holý O, Kasáková I, Hájek M, Lazarová A, Gonzalez-Rey C, Lasák J, Raclavský V, Čižnár I. Antibiotic susceptibility and production of endotoxin by Ochrobactrum anthropi isolated from environment and from patients with cystic fibrosis. Folia Microbiol (Praha) 2019;64:861-5. [PMID: 30919306 DOI: 10.1007/s12223-019-00700-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
94 Wang S, Zhang C, Xu X, Xu F, Zhou J, Wu Y, Cao C, Li W, Shen H, Cao J, Chen Z. Early growth response factor 1 is essential for cigarette smoke-induced MUC5AC expression in human bronchial epithelial cells. Biochemical and Biophysical Research Communications 2017;490:147-54. [DOI: 10.1016/j.bbrc.2017.06.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
95 Sahu I, Haque AKMA, Weidensee B, Weinmann P, Kormann MSD. Recent Developments in mRNA-Based Protein Supplementation Therapy to Target Lung Diseases. Mol Ther 2019;27:803-23. [PMID: 30905577 DOI: 10.1016/j.ymthe.2019.02.019] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
96 Kramer EL, Clancy JP. TGFβ as a therapeutic target in cystic fibrosis. Expert Opin Ther Targets 2018;22:177-89. [PMID: 29168406 DOI: 10.1080/14728222.2018.1406922] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
97 Belanger CR, Hancock REW. Testing physiologically relevant conditions in minimal inhibitory concentration assays. Nat Protoc 2021;16:3761-74. [PMID: 34215865 DOI: 10.1038/s41596-021-00572-8] [Reference Citation Analysis]
98 Whitsett JA, Alenghat T. Respiratory epithelial cells orchestrate pulmonary innate immunity. Nat Immunol. 2015;16:27-35. [PMID: 25521682 DOI: 10.1038/ni.3045] [Cited by in Crossref: 386] [Cited by in F6Publishing: 346] [Article Influence: 55.1] [Reference Citation Analysis]
99 Brown KJ, Seol H, Pillai DK, Sankoorikal BJ, Formolo CA, Mac J, Edwards NJ, Rose MC, Hathout Y. The human secretome atlas initiative: implications in health and disease conditions. Biochim Biophys Acta 2013;1834:2454-61. [PMID: 23603790 DOI: 10.1016/j.bbapap.2013.04.007] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
100 Corfield AP. Mucins: A biologically relevant glycan barrier in mucosal protection. Biochimica et Biophysica Acta (BBA) - General Subjects 2015;1850:236-52. [DOI: 10.1016/j.bbagen.2014.05.003] [Cited by in Crossref: 251] [Cited by in F6Publishing: 229] [Article Influence: 35.9] [Reference Citation Analysis]
101 Cross AR, Csatary EE, Raghuram V, Diggle FL, Whiteley M, Wuest WM, Goldberg JB. The histone-like protein AlgP regulon is distinct in mucoid and nonmucoid Pseudomonas aeruginosa and does not include alginate biosynthesis genes. Microbiology (Reading) 2020;166:861-6. [PMID: 32634088 DOI: 10.1099/mic.0.000923] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
102 Birk R, Händel A, Wenzel A, Kramer B, Aderhold C, Hörmann K, Stuck BA, Sommer JU. Heated air humidification versus cold air nebulization in newly tracheostomized patients. Head Neck 2017;39:2481-7. [PMID: 28990261 DOI: 10.1002/hed.24917] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
103 Michalski JE, Schwartz DA. Genetic Risk Factors for Idiopathic Pulmonary Fibrosis: Insights into Immunopathogenesis. J Inflamm Res 2020;13:1305-18. [PMID: 33447070 DOI: 10.2147/JIR.S280958] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
104 Birk SE, Serioli L, Cavallo V, Haagensen JAJ, Molin S, Nielsen LH, Zór K, Boisen A. Enhanced Eradication of Mucin-Embedded Bacterial Biofilm by Locally Delivered Antibiotics in Functionalized Microcontainers. Macromol Biosci 2021;21:e2100150. [PMID: 34117842 DOI: 10.1002/mabi.202100150] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
105 Chance DL, Mawhinney TP. Observations of, and Insights into, Cystic Fibrosis Mucus Heterogeneity in the Pre-Modulator Era: Sputum Characteristics, DNA and Glycoprotein Content, and Solubilization Time. JoR 2020;1:8-29. [DOI: 10.3390/jor1010002] [Reference Citation Analysis]
106 Garvin LM, Chen Y, Damsker JM, Rose MC. A novel dissociative steroid VBP15 reduces MUC5AC gene expression in airway epithelial cells but lacks the GRE mediated transcriptional properties of dexamethasone. Pulm Pharmacol Ther 2016;38:17-26. [PMID: 27133900 DOI: 10.1016/j.pupt.2016.04.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
107 Dalesio NM, Aksit MA, Ahn K, Raraigh KS, Collaco JM, McGrath-Morrow S, Zeitlin PL, An SS, Cutting GR. Cystic fibrosis transmembrane conductance regulator function, not TAS2R38 gene haplotypes, predict sinus surgery in children and young adults with cystic fibrosis. Int Forum Allergy Rhinol 2020;10:748-54. [PMID: 32282124 DOI: 10.1002/alr.22548] [Reference Citation Analysis]
108 Cendra MDM, Blanco-Cabra N, Pedraz L, Torrents E. Optimal environmental and culture conditions allow the in vitro coexistence of Pseudomonas aeruginosa and Staphylococcus aureus in stable biofilms. Sci Rep 2019;9:16284. [PMID: 31705015 DOI: 10.1038/s41598-019-52726-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
109 Jia Y, You X, Ma N, Li H, Liu G, Wang Y, Xue J, Shi J, Wei J, Li Y, Yang J, Liu X. Phenotypic Analysis of BrdU Label-Retaining Cells during the Maturation of Conducting Airway Epithelium in a Porcine Lung. Stem Cells Int 2019;2019:7043890. [PMID: 30936924 DOI: 10.1155/2019/7043890] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
110 Shen Y, Huang S, Kang J, Lin J, Lai K, Sun Y, Xiao W, Yang L, Yao W, Cai S, Huang K, Wen F. Management of airway mucus hypersecretion in chronic airway inflammatory disease: Chinese expert consensus (English edition). Int J Chron Obstruct Pulmon Dis 2018;13:399-407. [PMID: 29430174 DOI: 10.2147/COPD.S144312] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 4.8] [Reference Citation Analysis]
111 Zhu Y, Abdullah LH, Doyle SP, Nguyen K, Ribeiro CM, Vasquez PA, Forest MG, Lethem MI, Dickey BF, Davis CW. Baseline Goblet Cell Mucin Secretion in the Airways Exceeds Stimulated Secretion over Extended Time Periods, and Is Sensitive to Shear Stress and Intracellular Mucin Stores. PLoS One 2015;10:e0127267. [PMID: 26024524 DOI: 10.1371/journal.pone.0127267] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
112 Filipic B, Malesevic M, Vasiljevic Z, Lukic J, Novovic K, Kojic M, Jovcic B. Uncovering Differences in Virulence Markers Associated with Achromobacter Species of CF and Non-CF Origin. Front Cell Infect Microbiol 2017;7:224. [PMID: 28611955 DOI: 10.3389/fcimb.2017.00224] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
113 Yi B, Dalpke AH, Boutin S. Changes in the Cystic Fibrosis Airway Microbiome in Response to CFTR Modulator Therapy. Front Cell Infect Microbiol 2021;11:548613. [PMID: 33816324 DOI: 10.3389/fcimb.2021.548613] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
114 Sousa AM, Monteiro R, Pereira MO. Unveiling the early events of Pseudomonas aeruginosa adaptation in cystic fibrosis airway environment using a long-term in vitro maintenance. Int J Med Microbiol 2018;308:1053-64. [PMID: 30377031 DOI: 10.1016/j.ijmm.2018.10.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
115 Peters-Hall JR, Brown KJ, Pillai DK, Tomney A, Garvin LM, Wu X, Rose MC. Quantitative proteomics reveals an altered cystic fibrosis in vitro bronchial epithelial secretome. Am J Respir Cell Mol Biol 2015;53:22-32. [PMID: 25692303 DOI: 10.1165/rcmb.2014-0256RC] [Cited by in Crossref: 36] [Cited by in F6Publishing: 23] [Article Influence: 5.1] [Reference Citation Analysis]
116 Li J, Liu Y, Kim E, March JC, Bentley WE, Payne GF. Electrochemical reverse engineering: A systems-level tool to probe the redox-based molecular communication of biology. Free Radical Biology and Medicine 2017;105:110-31. [DOI: 10.1016/j.freeradbiomed.2016.12.029] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
117 Banjar H, Qeretli R, Ramadan A, Al-ibraheem A, Bnatig F. The first report on CFTR mutations of meconium ileus in cystic fibrosis population in Saudi Arabia: A single center review. International Journal of Pediatrics and Adolescent Medicine 2021. [DOI: 10.1016/j.ijpam.2021.03.008] [Reference Citation Analysis]
118 Messina G, Polito R, Monda V, Cipolloni L, Di Nunno N, Di Mizio G, Murabito P, Carotenuto M, Messina A, Pisanelli D, Valenzano A, Cibelli G, Scarinci A, Monda M, Sessa F. Functional Role of Dietary Intervention to Improve the Outcome of COVID-19: A Hypothesis of Work. Int J Mol Sci 2020;21:E3104. [PMID: 32354030 DOI: 10.3390/ijms21093104] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 31.0] [Reference Citation Analysis]
119 Bruscia EM, Bonfield TL. Innate and Adaptive Immunity in Cystic Fibrosis. Clin Chest Med 2016;37:17-29. [PMID: 26857765 DOI: 10.1016/j.ccm.2015.11.010] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 7.1] [Reference Citation Analysis]
120 Yuan Y, Zai Y, Xi X, Ma C, Wang L, Zhou M, Shaw C, Chen T. A novel membrane-disruptive antimicrobial peptide from frog skin secretion against cystic fibrosis isolates and evaluation of anti-MRSA effect using Galleria mellonella model. Biochim Biophys Acta Gen Subj 2019;1863:849-56. [PMID: 30802593 DOI: 10.1016/j.bbagen.2019.02.013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
121 Caparrós-Martín JA, Flynn S, Reen FJ, Woods DF, Agudelo-Romero P, Ranganathan SC, Stick SM, O'Gara F. The Detection of Bile Acids in the Lungs of Paediatric Cystic Fibrosis Patients Is Associated with Altered Inflammatory Patterns. Diagnostics (Basel) 2020;10:E282. [PMID: 32384684 DOI: 10.3390/diagnostics10050282] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
122 Millette G, Langlois JP, Brouillette E, Frost EH, Cantin AM, Malouin F. Despite Antagonism in vitro, Pseudomonas aeruginosa Enhances Staphylococcus aureus Colonization in a Murine Lung Infection Model. Front Microbiol 2019;10:2880. [PMID: 31921058 DOI: 10.3389/fmicb.2019.02880] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]